Through heat sterilisation.
From pasteurisation to full retort sterilisation, our variants retain function across the thermal processing that makes food shelf-stable.
We evolve proteins inside an extremophile. The ones that survive come out ready for what's next — searing heat, stomach acid, and the long road through.
01 The bottleneck
Proteins are the working parts of biology — and they are fragile by default. Heat denatures them. Low pH unfolds them. Digestive enzymes take them apart. Whatever a protein does on a bench, it usually stops doing somewhere between processing, storage, and digestion.
Engineering around this — making a protein both active and durable — has historically taken teams years and entire platforms of infrastructure. The problem isn't creativity; it's throughput. You can design ten thousand variants in an afternoon. Testing them for real survival is where time goes to die.
From pasteurisation to full retort sterilisation, our variants retain function across the thermal processing that makes food shelf-stable.
Selected in an acid-tolerant host, variants emerge with folding that doesn't unravel in wet-food matrices or in the stomach.
Protease resistance lets the protein survive its passage through the gut — emerging intact and still functional.
02 Our approach
Our screen runs inside a living extremophile — an organism that already tolerates the conditions we care about. Variants that can't survive simply don't make it through. The ones that do are real hits the first time you see them.
Libraries of protein variants — from thousands to millions, designed against a target function.
The library is expressed inside our extremophile host. The environment is the selection — variants that fold and function survive; the rest don't.
Hits come out already tested against the conditions they'll meet downstream. Weeks of wall-clock time, not months or years.
03 First application
Affineo is tackling durability where it matters most. In shelf-stable ingredients, wet-format products and functional nutrition, a fragile protein simply won't work. Ours are built to last.
We are developing proteins that target Fel d 1 — the main molecule responsible for cat allergies in humans. While existing approaches break down under heat and moisture and only work in dry kibble, our proteins are built to survive retort sterilisation and remain active in wet food. Functioning seamlessly as part of the cat's normal diet, they'll require no changes to the owner's routine.
Learn more about Fel d 1 programme04 Our team
05 Partners & programmes
Affineo is supported by Genopole — first through the Shaker programme, now through Gene.iO — and joins the latest Wilco One cohort for Foodtech & Agritech.




Food, nutrition, and companion-animal ingredient teams exploring durable protein additives.
Seed and strategic investors with conviction in platform biotech and food-grade biomanufacturing.